News > Over 2,000 patients benefited from plasma therapy in Delhi: Satyender Jain

Over 2,000 patients benefited from plasma therapy in Delhi: Satyender Jain

The Centre is considering to remove convalescent plasma therapy from the national clinical management protocol for COVID-19, a top ICMR official had said on Tuesday. A randomised controlled trial, led by the ICMR has shown that plasma therapy does not reduce mortality or prevent progression of COVID-19 from moderate to severe.

Delhi health minister Satyender Jain, himself a COVID-19 survivor, asserted that "this has helped save my life too."